Schonfeld Strategic Advisors LLC - Significant Ownership

Signature - Title
/s/ Hung Luc - Hung Luc, Chief Compliance Officer
Location
New York, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Schonfeld Strategic Advisors LLC.

Notify me when Schonfeld Strategic Advisors LLC files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Schonfeld Strategic Advisors LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
MRSN Mersana Therapeutics, Inc. Common Stock, par value $0.0001 per share 5.48% $2.12M -$41.9M 274K -95.2% Schonfeld Strategic Advisors LLC Sep 30, 2025
TERN Terns Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share 4.93% $12.6M -$2.71M 4.31M -17.8% Schonfeld Strategic Advisors LLC Mar 31, 2025
SKYE Skye Bioscience, Inc. Common Stock, par value $0.001 per share 3.6% $4.44M -$2M 1.12M -31% Schonfeld Strategic Advisors LLC Jun 30, 2025
APLT Applied Therapeutics, Inc. Common Stock, par value $0.0001 per share 3.3% $1.82M -$1.6M 4.68M -46.7% Schonfeld Strategic Advisors LLC Mar 31, 2025
RVPH Reviva Pharmaceuticals Holdings, Inc. Common Stock, par value $0.0001 per share 2.82% $1.16M 1.31M Schonfeld Strategic Advisors LLC Dec 31, 2024
FATE Fate Therapeutics, Inc. Common Stock, par value $0.001 per share 0.82% $1.05M -$7.68M 938K -88% Schonfeld Strategic Advisors LLC Jun 30, 2025

Schedules 13D/G Reported by Schonfeld Strategic Advisors LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.